Literature DB >> 9988122

Region specific expression of NMDA receptor NR1 subunit mRNA in hypothalamus and pons following chronic morphine treatment.

H Zhu1, C G Jang, T Ma, S Oh, R W Rockhold, I K Ho.   

Abstract

The NMDA receptor has been implicated in opioid tolerance and physical dependence. Using in situ hybridization techniques, the effects of chronic morphine treatment on the expression of mRNAs encoding the NMDA receptor subunits NRI, NR2A, and NR2B were investigated. A significant increase in the level of the NR1 subunit mRNA was found in the locus coeruleus and the hypothalamic paraventricular nucleus following 3 days of intracerebroventricular (i.c.v.) morphine infusion (26 nmol microl(-1) h(-1)) through osmotic minipumps. No changes were detected in expression of the NRI mRNA in the frontal cortex, caudate-putamen, nucleus accumbens, amygdala, CA1, CA2, and the dentate gyrus of the hippocampus, and in the central grey after morphine treatment. The expression of NR2A and NR2B subunit mRNAs did not change after morphine treatment in any brain region. These results suggest that changes in gene expression of the NRI subunit of the NMDA receptor are involved in the development of morphine tolerance and dependence.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9988122     DOI: 10.1016/s0014-2999(98)00861-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

1.  Modulation of NMDA receptor subunit mRNA in butorphanol-tolerant and -withdrawing rats.

Authors:  S Oh; J I Kim; M W Chung; I K Ho
Journal:  Neurochem Res       Date:  2000-12       Impact factor: 3.996

2.  The enigma of morphine tolerance: recent insights.

Authors:  S B Ray; S Wadhwa
Journal:  J Biosci       Date:  2001-12       Impact factor: 1.826

Review 3.  Control of ACTH secretion by excitatory amino acids: functional significance and clinical implications.

Authors:  Daniela Jezova
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.633

4.  Morphine and MK-801 administration leads to alternative N-methyl-D-aspartate receptor 1 splicing and associated changes in reward seeking behavior and nociception on an operant orofacial assay.

Authors:  E M Anderson; A Y Del Valle-Pinero; S K Suckow; T A Nolan; J K Neubert; R M Caudle
Journal:  Neuroscience       Date:  2012-04-21       Impact factor: 3.590

Review 5.  The Regulation of GluN2A by Endogenous and Exogenous Regulators in the Central Nervous System.

Authors:  Yongjun Sun; Liying Zhan; Xiaokun Cheng; Linan Zhang; Jie Hu; Zibin Gao
Journal:  Cell Mol Neurobiol       Date:  2016-06-02       Impact factor: 5.046

Review 6.  Glutamate receptors and nociception: implications for the drug treatment of pain.

Authors:  M E Fundytus
Journal:  CNS Drugs       Date:  2001-01       Impact factor: 5.749

7.  Chronic morphine treatment alters NMDA receptor-mediated synaptic transmission in the nucleus accumbens.

Authors:  G Martin; S H Ahmed; T Blank; J Spiess; G F Koob; G R Siggins
Journal:  J Neurosci       Date:  1999-10-15       Impact factor: 6.167

8.  NMDA receptor subunits change in the prefrontal cortex of pure-opioid and multi-drug abusers: a post-mortem study.

Authors:  Hamidreza Daneshparvar; Mitra-Sadat Sadat-Shirazi; Monir Fekri; Solmaz Khalifeh; Ali Ziaie; Nasrin Esfahanizadeh; Nasim Vousooghi; Mohammad-Reza Zarrindast
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-05-16       Impact factor: 5.270

Review 9.  Glutamatergic substrates of drug addiction and alcoholism.

Authors:  Justin T Gass; M Foster Olive
Journal:  Biochem Pharmacol       Date:  2007-06-30       Impact factor: 5.858

10.  Extensive neuroadaptive changes in cortical gene-transcript expressions of the glutamate system in response to repeated intermittent MDMA administration in adolescent rats.

Authors:  Anna M S Kindlundh-Högberg; Anna Blomqvist; Rana Malki; Helgi B Schiöth
Journal:  BMC Neurosci       Date:  2008-04-17       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.